Author: Mary Holloway
Now, ten months after the launch of the Bad Ad Program, Doctor Directory, a leading market service company for the healthcare industry, has conducted a survey of physician’s attitudes toward the initiative.
In the survey of over 1,000 practicing physicians, Doctor Directory found the following:
- While almost 90% said that they’d be at least “somewhat likely” to report questionable behavior, only 30% were aware of the program.
- Only 30% felt absolutely confident that they are qualified to determine what constitutes inappropriate advertising that could be deemed false, misleading, or off-label.
- 75% of respondents also reported that there is potential for abuse by some healthcare practitioners (HCPs) who may have a bias against, or dislike of, a specific pharma company or representative.
The results will certainly raise a lot of eyebrows. Healthcare companies have a hard enough time identifying the subtle behaviors of off-label promotion of their own products. Now, multiply that by the hundreds of different prescriptions and medical device procedures typically used by one physician. Asking physicians to make that call is a daunting task to say the least!
- “How Are Physicians Responding to the FDA’s Bad Ad Program?” and related posts (pharmagossip.blogspot.com)